1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNHLBI SBIR Phase IIB Small Market Awards is sponsored by National Heart, Lung, and Blood Institute (NHLBI), NIH. Supports small businesses in developing technologies for heart, lung, blood, and sleep disorders.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NHLBI Small Business Program | NHLBI, NIH NHLBI Small Business Program NHLBI Small Business Program The NHLBI is interested in Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) activities that advance the prevention, diagnosis, and treatment of heart, lung, blood, and sleep disorders.
Below is a list of funding opportunity announcements that offer small business entrepreneurs a chance to obtain funding without requirements to give up equity or ownership for early-stage research and development. Get answers to frequently asked questions about the NHLBI Small Business Program .
Learn more about the Innovation and Commercialization Office (I&C) , which coordinates the institute’s Small Business Program, offers services to SBIR/STTR applicants and awardees, provides digital education and online resources, and supports other SBIR/STTR awardee opportunities. Small Business Program Coordinator Julia Berzhanskaya, Ph. D.
NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) Notice of Special Interest (NOSI): Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal Health Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required) Notice of NHLBI Participation in NOT-AI-24-007 "Notice of Special Interest (NOSI): RNA Delivery Technologies to Allow Specific Tissue Target Homing (RNA-DASH)" Notice of Special Interest (NOSI): Translating Biomaterials-Based Technologies to Commercially Viable Products Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health Notice of Special Interest: Womens Health Research Notice of Special Interest (NOSI): Development of Functional Assay Sites to Evaluate Candidate -Omics Variants Associated with Heart, Lung, Blood, or Sleep Disease (R01, R41, R42, R43, R44) Innovation and Commercialization Office NHLBI's Small Business Program Frequently Asked Questions Small Business and Academic Innovation Success Stories NIH's Small Business Education and Entrepreneurial Development (SEED) website Innovation and Commercialization Office Inquiry Form
According to the current listing, eligibility includes: For-profit small businesses. Confirm the full requirements in the official notice before applying.
Applications for NHLBI SBIR Phase IIB Small Market Awards are due February 27, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
NHLBI SBIR Phase IIB Small Market Awards is funded by National Heart, Lung, and Blood Institute (NHLBI), NIH. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article